Savara Inc. announced that Dave Lowrance, its Chief Financial and Administrative Officer, will step down on July 15, 2026, due to health reasons. The company will separate financial and administrative duties, with COO Robert Lutz assuming the CFO role. This leadership change aims to ensure smooth financial management as Savara advances its clinical-stage biopharmaceutical programs, including MOLBREEVI for rare respiratory diseases. The transition reflects the company's focus on strong governance and operational continuity.
BeautyPlus, an AI-powered photo editing app by Pixocial, introduced the AI Tattoo Generator, allowing users to virtually try on realistic tattoo designs using their own photos. This feature helps users visualize different tattoo styles, placements, a...
rEvolution has been appointed by Hurricane Group as the agency of record for FISE Birmingham 2026, the only U.S. stop of the global FISE World Series action sports festival. The agency, alongside its digital group WePlay, will handle digital ticketin...
American Airlines Group will hold its virtual annual meeting of stockholders on June 10, 2026, at 9 a.m. CT. The meeting will be accessible to all interested parties through online registration, allowing stockholders to submit questions in writing du...
HERE, a lifestyle IP brand, has launched the fourth-generation WAKUKU series called The Handicraft World of WAKUKU, featuring vinyl plush blind boxes inspired by handcrafted aesthetics and themes of repair and emotional healing. This new collection i...
ZenaTech, a tech company specializing in AI-powered drones and related services, has been added to the Russell 3000 index effective June 29, 2026. This inclusion marks a significant milestone reflecting the company's growth and increased market capit...
